Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance

German F. Barbosa, Kresimira Milas

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Thyroid cancer is the most prevalent endocrine cancer whose incidence rates, particularly among women, have increased over the last decade. Although survival outcomes following surgery (with or without radioactive iodine ablation treatment) remain favorable, a significant proportion of patients are at lifetime risk of locoregional lymph node recurrence and distant metastasis. Serum thyroglobulin (Tg) has been the only circulating marker in routine use for detecting thyroid cancer recurrence, but it lacks sensitivity and is unreliable when Tg antibodies are present. New molecular markers for thyroid cancer have been investigated, with most based on detection in thyroid nodule or tumor tissue specimens. Recently, it has become possible to detect thyroid cancer cells in peripheral blood by measuring the mRNA of thyroid-specific genes, such as the mRNA of Tg and thyrotropin receptor. These have become promising new circulating markers for thyroid cancer. This review highlights the progress in this field from the perspective of improved initial cancer diagnosis and enhanced ability to monitor thyroid cancer recurrence.

Original languageEnglish (US)
Pages (from-to)1415-1424
Number of pages10
JournalExpert Review of Anticancer Therapy
Volume8
Issue number9
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Thyrotropin Receptors
Thyroid Neoplasms
Messenger RNA
Thyroglobulin
Recurrence
Endocrine Gland Neoplasms
Thyroid Nodule
Iodine
Neoplasms
Thyroid Gland
Lymph Nodes
Neoplasm Metastasis
Survival
Antibodies
Incidence
Serum
Genes

Keywords

  • Messenger
  • Neoplasm circulating cell
  • Receptor
  • Recurrence
  • RNA
  • Thyroglobulin
  • Thyroid cancer
  • Thyroid neoplasm
  • Thyrotropin
  • Tumor marker

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance. / Barbosa, German F.; Milas, Kresimira.

In: Expert Review of Anticancer Therapy, Vol. 8, No. 9, 2008, p. 1415-1424.

Research output: Contribution to journalArticle

@article{df4a5aad0fae4adc916330a3891636ec,
title = "Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance",
abstract = "Thyroid cancer is the most prevalent endocrine cancer whose incidence rates, particularly among women, have increased over the last decade. Although survival outcomes following surgery (with or without radioactive iodine ablation treatment) remain favorable, a significant proportion of patients are at lifetime risk of locoregional lymph node recurrence and distant metastasis. Serum thyroglobulin (Tg) has been the only circulating marker in routine use for detecting thyroid cancer recurrence, but it lacks sensitivity and is unreliable when Tg antibodies are present. New molecular markers for thyroid cancer have been investigated, with most based on detection in thyroid nodule or tumor tissue specimens. Recently, it has become possible to detect thyroid cancer cells in peripheral blood by measuring the mRNA of thyroid-specific genes, such as the mRNA of Tg and thyrotropin receptor. These have become promising new circulating markers for thyroid cancer. This review highlights the progress in this field from the perspective of improved initial cancer diagnosis and enhanced ability to monitor thyroid cancer recurrence.",
keywords = "Messenger, Neoplasm circulating cell, Receptor, Recurrence, RNA, Thyroglobulin, Thyroid cancer, Thyroid neoplasm, Thyrotropin, Tumor marker",
author = "Barbosa, {German F.} and Kresimira Milas",
year = "2008",
doi = "10.1586/14737140.8.9.1415",
language = "English (US)",
volume = "8",
pages = "1415--1424",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "9",

}

TY - JOUR

T1 - Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance

AU - Barbosa, German F.

AU - Milas, Kresimira

PY - 2008

Y1 - 2008

N2 - Thyroid cancer is the most prevalent endocrine cancer whose incidence rates, particularly among women, have increased over the last decade. Although survival outcomes following surgery (with or without radioactive iodine ablation treatment) remain favorable, a significant proportion of patients are at lifetime risk of locoregional lymph node recurrence and distant metastasis. Serum thyroglobulin (Tg) has been the only circulating marker in routine use for detecting thyroid cancer recurrence, but it lacks sensitivity and is unreliable when Tg antibodies are present. New molecular markers for thyroid cancer have been investigated, with most based on detection in thyroid nodule or tumor tissue specimens. Recently, it has become possible to detect thyroid cancer cells in peripheral blood by measuring the mRNA of thyroid-specific genes, such as the mRNA of Tg and thyrotropin receptor. These have become promising new circulating markers for thyroid cancer. This review highlights the progress in this field from the perspective of improved initial cancer diagnosis and enhanced ability to monitor thyroid cancer recurrence.

AB - Thyroid cancer is the most prevalent endocrine cancer whose incidence rates, particularly among women, have increased over the last decade. Although survival outcomes following surgery (with or without radioactive iodine ablation treatment) remain favorable, a significant proportion of patients are at lifetime risk of locoregional lymph node recurrence and distant metastasis. Serum thyroglobulin (Tg) has been the only circulating marker in routine use for detecting thyroid cancer recurrence, but it lacks sensitivity and is unreliable when Tg antibodies are present. New molecular markers for thyroid cancer have been investigated, with most based on detection in thyroid nodule or tumor tissue specimens. Recently, it has become possible to detect thyroid cancer cells in peripheral blood by measuring the mRNA of thyroid-specific genes, such as the mRNA of Tg and thyrotropin receptor. These have become promising new circulating markers for thyroid cancer. This review highlights the progress in this field from the perspective of improved initial cancer diagnosis and enhanced ability to monitor thyroid cancer recurrence.

KW - Messenger

KW - Neoplasm circulating cell

KW - Receptor

KW - Recurrence

KW - RNA

KW - Thyroglobulin

KW - Thyroid cancer

KW - Thyroid neoplasm

KW - Thyrotropin

KW - Tumor marker

UR - http://www.scopus.com/inward/record.url?scp=55249098901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249098901&partnerID=8YFLogxK

U2 - 10.1586/14737140.8.9.1415

DO - 10.1586/14737140.8.9.1415

M3 - Article

C2 - 18759693

AN - SCOPUS:55249098901

VL - 8

SP - 1415

EP - 1424

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 9

ER -